UMMC Navigation

Cancer Institute

The Cancer Institute unites physicians, nurses and researchers from the University of Mississippi Medical Center and the University of Mississippi in the quest to stop cancer through:

  • Interdisciplinary world class cancer prevention, detection and treatment.
  • Research to better prevent, detect and treat cancer.
  • Education for Mississippi residents and the medical caregivers who one day will provide their cancer care.

Adult and pediatric physicians see more than 2,000 new patients annually and follow more than 5,800 survivors. Cancer teams see many people with rare or complex care needs.

Hear from Our Director

Dr. John “Jack” Ruckdeschel, Cancer Institute director, describes what it takes to excel in cancer care.


Interdisciplinary teams meet regularly to review each new patient’s case and recommend the best treatment for each individual. Doctors here see many unusual and complex cases.



The Cancer Institute offers the state’s only residency and fellowship programs for professionals seeking a career in cancer care.



Researchers and physicians at UMMC and at the University of Mississippi are working together to seek new and better ways to prevent, detect and treat cancer.


Latest News

David Bowman, left, a former cancer patient, shows his harmonicas to CICU staff members, from left, Cynthia Gonzalez, housekeeper, Don Horn, nurse manager, and Presly Lowry, R.N.

Screening, early detection make lung cancer ‘highly curable’

Thursday, November 9, 2017

A Pelahatchie man is encouraging others who are long-time smokers to investigate low-dose CT screening for possible lung cancer. Lung cancer, usually diagnosed after symptoms become apparent, often is too advanced to offer a high chance of success. Screening helps reverse those odds.

Read More
Dr. Chunli

Gamma Knife offers noninvasive care for brain tumors

Thursday, November 2, 2017

The UMMC Cancer Institute and the Department of Radiation Oncology installed the equipment in May to provide nonsurgical therapy for patients with malignant or benign brain tumors, brain metastases or other conditions. It’s pinpoint precision delivers therapy to tumors with less damage to healthy tissue.

Read More